New hope for bulging eyes: drug trial targets thyroid eye disease
NCT ID NCT07462130
First seen Mar 30, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study tests a new drug called NTB003 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 74 adults aged 18 to 75 with active disease will receive the drug to see if it safely reduces eye bulging and inflammation. The goal is to find a better treatment option for this chronic condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.